KRAS mutations: An old oncogene becomes a new predictive biomarker Journal Article

   

Authors:	Riely, G. J.; Ladanyi, M.
Article Title:	KRAS mutations: An old oncogene becomes a new predictive biomarker
Keywords:	cancer chemotherapy; cancer survival; protein expression; gene mutation; proto-oncogene proteins; clinical trial; erlotinib; fluorouracil; monotherapy; note; neoplasms; colorectal cancer; biological markers; imatinib; lung non small cell cancer; epidermal growth factor receptor; epidermal growth factor receptor 2; combination chemotherapy; receptor, epidermal growth factor; mutational analysis; cetuximab; cancer research; oncogenes; irinotecan; panitumumab; lung adenocarcinoma; fluorescence in situ hybridization; folinic acid; gefitinib; bcr abl protein; ras proteins; oncogene k ras; oxaliplatin; k ras protein
Journal Title:	Journal of Molecular Diagnostics
Volume:	10
Issue:	6
ISSN:	1525-1578
Publisher:	Elsevier Science, Inc.
Date Published:	2008-11-01
Start Page:	493
End Page:	495
Language:	English
DOI:	10.2353/jmoldx.2008.080105
PUBMED:	18832458
PROVIDER:	scopus
PMCID:	PMC2570631
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-55949122976&partnerID=40&md5=e44aa6fec40e630df059c7745bc69e1b
Notes:	--- - "Cited By (since 1996): 10" - "Export Date: 17 November 2011" - "CODEN: JMDIF" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15210